Integra Holdings
Venture Capital
Active
Jerusalem, Israel
8
7M
7
0.25
6
0.12
- Areas of investment
Summary
Integra Holdings is the famous VC, which was founded in 1989. The company was established in Europe in Switzerland. The main department of described VC is located in the Wallisellen.
We can highlight the next thriving fund investment areas, such as Clinical Trials, Therapeutics. Among the various public portfolio startups of the fund, we may underline Atox Bio Besides, a startup requires to be at the age of 11-15 years to receive the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Israel.
The top activity for fund was in 2017. The common things for fund are deals in the range of 10 - 50 millions dollars. Speaking about the real fund results, this VC is 66 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year.
The typical case for the fund is to invest in rounds with 2 participants. Despite the Integra Holdings, startups are often financed by SR One, OrbiMed, Lundbeckfonden Ventures. The meaningful sponsors for the fund in investment in the same round are The Becker Group, SR One, OrbiMed.
Investor highlights
- Industry focus
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 8
- Lead investments
- 6
- Rounds per year
- 0.25
- Follow on index
- 0.12
- Investments by industry
- Pharmaceutical (6)
- Biotechnology (6)
- Life Science (5)
- Medical (2)
- Health Care (2) Show 2 more
- Investments by region
-
- Israel (8)
- Peak activity year
- 2014
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 7
- Group Appearance index
- 0.25
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Splisense | 13 May 2021 | Biotechnology, Life Science, Pharmaceutical | Early Stage Venture | 28M | Jerusalem District, Jerusalem, Israel |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.